Erectile Dysfunction Devices Market Size, Share and Forecast 2026 to 2035

Report Id: 1947 Pages: 180 Last Updated: 06 February 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Erectile Dysfunction Devices Market Size is valued at USD 1.98 Billion in 2025 and is predicted to reach USD 5.23 Billion by the year 2035 at a 10.3% CAGR during the forecast period for 2026 to 2035. 

Erectile Dysfunction Devices Market Size, Share & Trends Analysis Report by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, Others), By Approach (Invasive and Non-Invasive), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs)), Region and Segment Forecasts, 2026 to 2035.

Erectile Dysfunction Devices Market Size

Key Industry Insights & Findings from the Report:

  • The growing prevalence of prostate cancer and other underlying health conditions are driving the erectile dysfunction market.
  • Erectile dysfunction devices offer a non-invasive, drug-free alternative, appealing to patients seeking convenience and discretion, thus driving market growth.
  • North America dominated the market and accounted for a global revenue share in 2025.
  • Low awareness regarding prostate health among men poses a challenge for the erectile dysfunction market.

Patients with erectile dysfunction initially choose non-surgical alternatives such as injections, oral phosphodiesterase type-5 inhibitors (Viagra, Cialis, and others), suppositories, and penile pumps. The most popular choice for men seeking treatment for erectile dysfunction, however, is a penile implant if a patient does not respond to any of the aforementioned treatments.

According to the Cleveland Clinic, a non-profit academic medical centre with headquarters in Ohio, the United States, about 20,000 American males choose to have a penile implant each year. In the United States, penile implants are a common treatment choice, which is expected to spur market expansion over the upcoming years. Numerous awareness programmes focusing on the treatment of erectile dysfunction must be launched due to the condition's increased prevalence. Many companies, including Pfizer, are focusing on starting erectile dysfunction awareness programmes.

European impotence awareness campaigns and unbranded erectile dysfunction awareness campaigns aimed towards younger men are a couple of notable examples. For instance, in the United States, February 14 is recognised as National Impotence Day, on which the government and healthcare professionals raise public awareness of erectile dysfunction, its causes, and the range of treatment options available. They also pay attention to the various forms of erectile dysfunction and how it affects mental health. 

Competitive Landscape:

Some of the Erectile Dysfunction Devices market players are:

  • Boston Scientific Corporation
  • Coloplast Group
  • Rigicon, Inc.
  • Promedon Gmbh
  • Zephyr Surgical Implants
  • Owen Mumford Ltd.
  • Augusta Medical Systems Llc
  • Shenzhen Huikang Medical Apparatus Co., Ltd.
  • Zimmer Medizinsysteme Gmbh
  • Medispec Ltd.
  • Mts Medical Ug
  • Novamedtek
  • Storz Medical Ag
  • The Elator
  • Timm Medical
  • Ohh-Med Medical Ltd.
  • Comphya Sa
  • Direxgroup
  • Advin Health Care
  • Giddy
  • Global Life Technologies Ltd. 

Market Segmentation:

The Erectile Dysfunction Devices market is segmented on the basis of treatment type, approach, and end user. Treatment type segment includes Shockwave Therapy Devices,  Penile Implants, Vacuum Therapy Devices, and Others. Approach segments include Invasive and Non-invasive implants. End user segment includes Hospitals & Clinics, Ambulatory Surgery Centers, Pharmacies, and Others.

Based On Treatment Type, The Penile Implant Segment Is Accounted As A Major Contributor In The Erectile Dysfunction Devices Market

The penile implant category is expected to hold a major share of the global Erectile Dysfunction Devices market. Vacuum constriction devices, penile implants, shockwave therapy, and other device types are the main segments of the worldwide erectile dysfunction devices market. The market category expected to experience the highest growth rate is shockwave therapy. The non-invasive nature of the procedure, the absence of tablets or other pharmaceuticals, the expansion of companies making shockwave devices, and the rise of research into the use of shockwave therapy for the treatment of erectile dysfunction are expected to notice favourable market growth during the forecast period.

The Ambulatory Surgery Centers Segment Witnessed Growth At A Rapid Rate

Due to a number of factors, the ambulatory surgical centres (ASCs) sector is anticipated to experience the most noteworthy growth in the market for erectile dysfunction devices. First off, ASCs offer a practical and affordable alternative for outpatient operations, such as the installation of devices for erectile dysfunction. They provide a welcoming and specialised setting that is furnished with the tools and qualified medical personnel required to carry out these treatments. Second, the demand for procedures carried out in ASCs is fueled by patients and healthcare professionals' growing desire for minimally invasive therapies.

In addition to improving patient happiness, this section enables shorter hospital stays, fewer post-operative problems, and quicker recovery times. This area of the market for erectile dysfunction products is also growing due to the growing healthcare infrastructure and the increase in ASCs around the world.

In The Region, The North America Erectile Dysfunction Devices Market Holds A Significant Revenue Share

The erectile dysfunction devices market is expected to be dominated by the North American region for a number of reasons. Due to reasons including an ageing population and concerns with lifestyle, erectile dysfunction is pervasive in North America. This generates a sizable patient pool and increases the need for erectile dysfunction devices in the area. Second, the region has a state-of-the-art healthcare infrastructure, cutting-edge technology, and an advantageous reimbursement system that encourages the adoption of these devices.

Erectile Dysfunction Devices Market

The dominance of the North American segment in the erectile dysfunction devices market is also attributed to the existence of significant market participants, intensive research and development efforts, and a strong focus on men's health. Increased understanding and acceptance of erectile dysfunction as a curable ailment further add fuel to the market. Furthermore, the Asia Pacific region remains the fastest-growing market.

Recent Developments:

  • In Nov 2023, Boston Scientific has received FDA approval for the Tenacio pump component of the AMS 700 inflatable penile prosthesis (IPP). The AMS 700 IPP provides a therapeutic alternative for individuals suffering from erectile dysfunction.
  • In September 2023, Ohh-Med Medical established a presence in the UK, introducing a nonpharmaceutical treatment option for erectile dysfunction, thus broadening accessibility to the Vertica medical device.

Erectile Dysfunction Devices Market Report Scope:

Report Attribute Specifications
Market Size Value In 2025 USD 1.98 Billion 
Revenue Forecast In 2035 USD 5.23 Billion
Growth Rate CAGR CAGR of 10.3% from 2026 to 2035
Quantitative Units Representation of revenue in US$ Bn, volume (number of units) and CAGR from 2026 to 2035
Historic Year 2022 to 2025
Forecast Year 2026-2035
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered Treatment Type, Approach, And End User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia
Competitive Landscape Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz Medical AG, Promedon, The Elator, Timm Medical, and Silimed
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Segmentation of Erectile Dysfunction Devices Market :

Erectile Dysfunction Devices Market, By Treatment Type-

  • Penile Implants
  • Shockwave Therapy Devices
  • Vacuum Therapy Devices
  • Others 

Erectile Dysfunction Devices Market

Erectile Dysfunction Devices Market, By Approach-

  • Invasive
  • Non-Invasive

Erectile Dysfunction Devices Market, By End User-

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Pharmacies
  • Others

Erectile Dysfunction Devices Market, By Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5091
Security Code field cannot be blank!

Frequently Asked Questions

Erectile Dysfunction Devices Market Size is valued at USD 1.98 Billion in 2025 and is predicted to reach USD 5.23 Billion by the year 2035

Erectile Dysfunction Devices Market expected to grow at a 10.3% CAGR during the forecast period for 2026 to 2035.

Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz Medical AG, Promedon, The Elator, Timm Medical, Silimed and Other.

Erectile Dysfunction Devices Market is segmented in Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, Others), By Approach (Invasive and Non-Invasive), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs)) and Other.

North America region is leading the Erectile Dysfunction Devices Market.
Get Sample Report Enquiry Before Buying